Eckel-Passow et al. [19] scored tumors according to the IDH mutation, mutations in the TERT (telomerase reverse transcriptase) promoter, and the codeletion of 1p19q in 1087 gliomas and 11590 controls. The gene discussed is IDH2; the disease is glioma.